We are live on
!
Find out more
Balyasny Asset Management Portfolio holdings
AUM
$77.1B
1-Year Est. Return
42.89%
This Fund
S&P 500
This Quarter
Est. Return
+7.96%
1 Year Est. Return
+42.89%
3 Year Est. Return
+126.29%
5 Year Est. Return
+172.74%
10 Year Est. Return
+1,026.86%
AUM
$78.8B
AUM Growth
-$135M
(-0.17%)
Cap. Flow
-$4.13B
Cap. Flow
% of AUM
-5.25%
Top 10 Holdings %
Top 10 Hldgs %
14.64%
Holding
3,669
New
809
Increased
1,002
Reduced
1,102
Closed
643
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$807M |
| 2 |
Alphabet (Google) Class A
GOOGL
|
+$497M |
| 3 |
RNAM
Avidity Biosciences
RNAM
|
+$390M |
| 4 |
Kenvue
KVUE
|
+$379M |
| 5 |
Broadcom
AVGO
|
+$324M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$409M |
| 2 |
Visa
V
|
+$354M |
| 3 |
Advanced Micro Devices
AMD
|
+$328M |
| 4 |
Meta Platforms (Facebook)
META
|
+$317M |
| 5 |
Lockheed Martin
LMT
|
+$316M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 11.61% |
| 2 | Consumer Discretionary | 9.64% |
| 3 | Healthcare | 8.17% |
| 4 | Industrials | 8.1% |
| 5 | Financials | 8.05% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2401
CALL
Madrigal Pharmaceuticals
MDGL
$12.2B
| $582K | ﹤0.01% |
1,000
-1,600
| -62% | -$817K |
|
|
2402
PUT
Madrigal Pharmaceuticals
MDGL
$12.2B
| $582K | ﹤0.01% |
1,000
-1,100
| -52% | -$562K |
|
|
SFIX
2403
Stitch Fix
SFIX
$487M
| $581K | ﹤0.01% |
+110,683
| New | +$505K |
|
|
CIM
2404
Chimera Investment
CIM
$1,000M
| $581K | ﹤0.01% |
46,714
-265,853
| -85% | -$3.38M |
|
2405
Brookdale Senior Living
BKD
$3.11B
| $580K | ﹤0.01% |
53,764
+489
| +0.9% | +$4.81K |
|
2406
PBF Energy
PBF
$8.53B
| $577K | ﹤0.01% |
21,263
+2,904
| +16% | +$93K |
|
2407
ARK Innovation ETF
ARKK
$6.48B
| $575K | ﹤0.01% |
7,475
-36,876
| -83% | -$3.05M |
|
2408
PUT
Archer Daniels Midland
ADM
$38.9B
| $575K | ﹤0.01% |
10,000
| – | – |
|
2409
Texas Pacific Land
TPL
$23.9B
| $575K | ﹤0.01% |
2,001
-2,463
| -55% | -$752K |
|
|
GRDN
2410
Guardian Pharmacy Services
GRDN
$2.44B
| $573K | ﹤0.01% |
+19,033
| New | +$539K |
|
2411
ENI
E
$78.7B
| $571K | ﹤0.01% |
+15,050
| New | +$553K |
|
2412
KT
KT
$9.08B
| $571K | ﹤0.01% |
30,095
+5,388
| +22% | +$100K |
|
2413
Nuveen Municipal Credit Opportunities Fund
NMCO
$585M
| $567K | ﹤0.01% |
+55,468
| New | +$593K |
|
2414
CALL
Shift4
FOUR
$3.65B
| $567K | ﹤0.01% |
9,000
-14,500
| -62% | -$1.02M |
|
2415
CALL
Prudential Financial
PRU
$42.6B
| $564K | ﹤0.01% |
5,000
| – | – |
|
2416
State Street
STT
$52.1B
| $564K | ﹤0.01% |
4,369
+1,662
| +61% | +$199K |
|
2417
PUT
PNC Financial Services
PNC
$102B
| $564K | ﹤0.01% |
2,700
-2,700
| -50% | -$521K |
|
2418
Aegon
AEG
$13.8B
| $562K | ﹤0.01% |
+72,844
| New | +$557K |
|
2419
Hewlett Packard
HPE
$82.2B
| $562K | ﹤0.01% |
23,377
-3,471,099
| -99% | -$81.8M |
|
|
EXAS
2420
PUT
DELISTED
Exact Sciences
EXAS
| $559K | ﹤0.01% |
+5,500
| New | +$442K |
|
2421
Bank First Corp
BFC
$1.76B
| $559K | ﹤0.01% |
+4,585
| New | +$584K |
|
2422
CTS Corp
CTS
$1.8B
| $557K | ﹤0.01% |
12,992
+7,636
| +143% | +$320K |
|
2423
CALL
Xtrackers Harvest CSI 300 China A-Shares ETF
ASHR
$1.59B
| $555K | ﹤0.01% |
+16,900
| New | +$554K |
|
2424
Paychex
PAYX
$43.1B
| $554K | ﹤0.01% |
4,939
-20,391
| -81% | -$2.39M |
|
2425
Corcept Therapeutics
CORT
$12B
| $552K | ﹤0.01% |
15,852
-16,995
| -52% | -$1.33M |
|
Similar funds
BC
Balyasny Asset Management's Q4 2025 Portfolio in Review
As of Q4 2025, Balyasny Asset Management held 3,669 positions worth $78.8B, down 0.17% from $78.9B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
Balyasny Asset Management withdrew a net $4.13B in Q4 2025, closing 643 positions and reducing 1,102 holdings. Its most notable exit was Mr. Cooper, an estimated $277M position sold in full.
By sector, the portfolio is most concentrated in Technology at 12% of assets, down from 12% a quarter earlier, followed by Consumer Discretionary and Healthcare.
Against the trend, Balyasny Asset Management opened a new position in Avidity Biosciences worth $436M.
- Balyasny Asset Management's largest Q4 2025 buy was Avidity Biosciences: 6,040,590 shares worth $436M.
- Balyasny Asset Management added most to Amazon in Q4 2025, an estimated $807M increase.
- Balyasny Asset Management's biggest Q4 2025 reduction was Apple, cutting an estimated $409M.
- Balyasny Asset Management fully exited Mr. Cooper in Q4 2025, selling an estimated $277M.
- Balyasny Asset Management's ten largest holdings make up 15% of its $78.8B portfolio in Q4 2025.
- Balyasny Asset Management opened 809 new positions and closed 643 in Q4 2025.
- Balyasny Asset Management's portfolio value fell 0.17% quarter-over-quarter to $78.8B.
Based on Balyasny Asset Management's 13F filing for Q4 2025, filed 17 Feb 2026.